Reproterol

Reproterol is a bronchodilator and a beta-2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a sympathomimetic drug that acts on the beta-2 adrenergic receptor, leading to relaxation of smooth muscle in the airways and improved airflow.

Pharmacology[edit | edit source]

Reproterol is a beta-2 adrenergic receptor agonist, which means it stimulates these receptors in the lungs. This leads to relaxation of the smooth muscle in the airways, allowing them to widen and making it easier for air to flow in and out of the lungs. This can help to relieve symptoms of conditions like asthma and COPD, such as shortness of breath, wheezing, and coughing.

Clinical Use[edit | edit source]

Reproterol is used in the treatment of respiratory diseases characterized by constriction of the airways. These include asthma, a chronic condition characterized by recurrent attacks of breathlessness and wheezing, and COPD, a group of lung diseases that cause airflow blockage and breathing-related problems.

Side Effects[edit | edit source]

Like all medicines, Reproterol can cause side effects, although not everybody gets them. Common side effects include tachycardia (fast heart rate), palpitations, tremor, and nervousness. Less common side effects include hypokalemia (low potassium levels in the blood), hyperglycemia (high blood sugar levels), and hypotension (low blood pressure).

Contraindications[edit | edit source]

Reproterol should not be used in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in patients with cardiac arrhythmias, uncontrolled hypertension, and hyperthyroidism.